The Food and Drug Administration said Friday it intends to restrict access to GLP-1 drug ingredients used in nonapproved compounded weight-loss products and that Hims & Hers Health Inc. could face federal enforcement, a move the agency said is aimed at curbing mass-marketed …
La scivolata del francese e il belga fermato da un treno: scene da una cerimonia di apertura
Febbraio 7, 2026
Read More [#item_full_content]
